EGM
PTCT icon

Engineers Gate Manager’s PTC Therapeutics PTCT Stock Holding History

Engineers Gate Manager’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.22M Sell
27,276
-18,878
-41% -$1.36M 0.03% 635
2026
Q1 		$3.14M Buy
46,154
+9,445
+26% +$669K 0.04% 538
2025
Q4 		$2.79M Buy
36,709
+25,486
+227% +$1.85M 0.03% 555
2025
Q3 		$689K Sell
11,223
-13,131
-54% -$684K 0.01% 1363
2025
Q2 		$1.19M Sell
24,354
-36,622
-60% -$1.74M 0.01% 1023
2025
Q1 		$3.11M Buy
60,976
+24,683
+68% +$1.23M 0.05% 520
2024
Q4 		$1.64M Sell
36,293
-11,736
-24% -$502K 0.03% 716
2024
Q3 		$1.78M Sell
48,029
-46,256
-49% -$1.55M 0.03% 700
2024
Q2 		$2.88M Buy
94,285
+28,579
+43% +$926K 0.07% 414
2024
Q1 		$1.91M Sell
65,706
-3,809
-5% -$107K 0.05% 496
2023
Q4 		$1.92M Buy
69,515
+21,912
+46% +$501K 0.05% 497
2023
Q3 		$1.07M Buy
47,603
+39,935
+521% +$1.49M 0.04% 677
2023
Q2 		$312K Buy
+7,668
New +$375K 0.01% 1292
2023
Q1 		– Sell
-9,864
Closed -$377K – 1938
2022
Q4 		$377K Buy
9,864
+458
+5% +$19K 0.02% 1079
2022
Q3 		$472K Buy
9,406
+2,638
+39% +$129K 0.03% 854
2022
Q2 		$271K Sell
6,768
-236
-3% -$8.28K 0.01% 1479
2022
Q1 		$261K Buy
+7,004
New +$270K 0.01% 1490
2021
Q4 		– Sell
-27,116
Closed -$1.01M – 2241
2021
Q3 		$1.01M Buy
+27,116
New +$1.11M 0.06% 492
2021
Q2 		– Sell
-5,660
Closed -$268K – 1934
2021
Q1 		$268K Sell
5,660
-4,338
-43% -$258K 0.01% 1392
2020
Q4 		$610K Sell
9,998
-151
-1% -$8.9K 0.03% 858
2020
Q3 		$474K Buy
+10,149
New +$500K 0.02% 1023
2020
Q2 		– Sell
-16,824
Closed -$751K – 1932
2020
Q1 		$751K Buy
16,824
+9,463
+129% +$476K 0.05% 554
2019
Q4 		$354K Sell
7,361
-16,811
-70% -$714K 0.02% 1174
2019
Q3 		$817K Buy
+24,172
New +$1.05M 0.04% 598

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Engineers Gate Manager's PTCT Position: Q2 2026 in Review

Engineers Gate Manager reduced its PTC Therapeutics (PTCT) stake by 41% in Q2 2026, selling an estimated $1.36M and leaving 27,276 shares worth $2.22M. The position accounts for 0.03% of the portfolio, ranked #635.

Engineers Gate Manager first reported a position in PTCT in Q3 2019 and has held it in 24 quarters since. The position peaked at $3.14M in Q1 2026. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Engineers Gate Manager held 27,276 shares of PTC Therapeutics worth $2.22M as of Q2 2026.
  • Engineers Gate Manager sold 18,878 PTC Therapeutics shares in Q2 2026, an estimated $1.36M.
  • PTC Therapeutics made up 0.03% of Engineers Gate Manager's portfolio in Q2 2026, its #635 holding.
  • Engineers Gate Manager first reported a position in PTC Therapeutics in Q3 2019 and has held it in 24 quarters since.
  • Engineers Gate Manager's PTC Therapeutics position peaked at $3.14M in Q1 2026.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.